3种药物治疗老年人严重肺部感染的药物经济学分析
Pharmacoeconomics analysis of 3 drugs in the treatment of lower respiratory tract infections in the elderly
-
摘要: 目的 探讨3种药物治疗老年人严重肺部感染的经济学效果。方法 选用文献治疗老年人严重肺部感染的3种药物治疗方案(A-头孢哌酮/舒巴坦、B-亚胺培南/西司他丁与C-头孢他啶),运用费用-效果分析方法进行评价。结果 C方案是治疗老年人严重肺部感染的3种药物治疗方案的最佳方案。结论 费用-效果分析方法在优化治疗方案,指导经济、合理用药等方面有着重要作用。Abstract: Objective To evaluate the economic effectiveness of 3 therapeutic schemes for lower respiratory tract infection in the elderly. Methods Three schemes of the treatment of lower respiratory tract infection in the elderly from literatrure cefoperazone/sulbactam(A), imipenem/cilastatin(B), ceftazidime(C) were selected. Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. Results According to the evaluation by cost-effectiveness analysis, C was the best scheme. Conclusion The cost-effectiveness analysis is very important in optimizing therapeutic scheme, guiding rational drug use and increasing economic effectiveness.
计量
- 文章访问数: 2011
- HTML全文浏览量: 214
- PDF下载量: 281
- 被引次数: 0